#United States #Salt Lake City #Frost & Sullivan #Health Catalyst #Population Health Management

Health Catalyst Recognized as a Leader in Innovation

On January 13, 2025, Health Catalyst, Inc. (Nasdaq: HCAT), a prominent provider of analytics technology and services for healthcare organizations, celebrated its recognition in the Frost Radar™ US Population Health Management, 2024 report. This distinction marks Health Catalyst as a leader in the fiercely competitive market of population health management (PHM).

Frost & Sullivan's analysts meticulously evaluated over 50 companies in the U.S. PHM sector, focusing on their innovation and growth strategies, and highlighted those making significant advancements in healthcare. In this report, Health Catalyst stands out for its innovative Population Health suite, which offers clients robust benchmarks for financial and quality metrics, essential administrative support, and advanced analytics aimed at improving healthcare delivery and patient outcomes.

The report specifically acknowledges how Health Catalyst optimizes third-party PHM IT initiatives, enhancing their effectiveness. It mentions features like custom configurations, a pre-built rules engine, and advanced data management capabilities as critical elements that contribute to the success of PHM initiatives.

Dan Burton, CEO of Health Catalyst, expressed pride in the company’s recognition in the 2024 Frost Radar™ report, stating, “This achievement reflects our ongoing commitment to tackling the most pressing issues in healthcare through innovative and client-focused solutions. We take immense pride in contributing to the shift towards value-based care and empowering healthcare organizations with essential tools to improve healthcare quality, operational efficiency, and patient outcomes.”

The report also emphasizes Health Catalyst's proactive innovation strategy, which continually addresses significant industry challenges while incorporating feedback from clients to keep solutions aligned with evolving trends. Furthermore, it notes Health Catalyst's strategic movements into underserved areas, particularly targeting smaller healthcare organizations and ambulatory practices, which fortify its leadership within the PHM market.

In a broader context, Health Catalyst’s approach of balancing growth and innovation positions it favorably to ensure the success of its population health management initiatives. The comprehensive and adaptable nature of its PHM portfolio is designed to cater to the diverse needs of clients across various scales, which is further enhanced by the introduction of sophisticated data management tools and systems.

In addition to its existing initiatives, Health Catalyst has strengthened its capabilities through acquisitions like Carevive and Lumeon, focusing on oncology care management and advanced patient communication systems. Analysts from Frost & Sullivan praised these acquisitions for enhancing Health Catalyst’s offering and demonstrating its commitment to meet evolving market demands effectively.

About Health Catalyst: Health Catalyst is at the forefront of healthcare transformation, leveraging data and analytics technology to spark improvements in clinical, operational, and financial outcomes. Over 1,000 organizations worldwide utilize Health Catalyst’s solutions, including its cloud-based platform, Health Catalyst Ignite™, which facilitates actionable insights from complex healthcare data. The company’s dedication to innovation and measurable results has positioned it as a catalyst for substantial, informed improvements in healthcare.

With a legacy built on years of successful initiatives and measurable results worth billions of dollars, Health Catalyst continues its mission to enable data-driven healthcare enhancements and greater operational effectiveness, ultimately propelling better patient outcomes in a rapidly evolving medical landscape.